HEDS Reference Set Application: Amit Singal, UTSW (2021) Prognostic Liver Secretome signature Validation

Abbreviated Name
HEDS Ref Set App: Singal (2021) PLSec
Lead Investigator
Singal, AmitUT Southwestern Medical Center
Coordinating Investigator
Feng, Ziding Fred Hutchinson Cancer Center
Involved Investigators

Abstract

see objectives

Aims

To validate the performance of a blood-based molecular signature, Prognostic Liver Secretome signature (PLSec), to predict long-term risk of developing HCC in cirrhosis patients.

Analytic Method

Biomarker will be run blinded to clinical outcome

Outcome

Validate predictive biomarker for development of HCC in patients with cirrhosis

Publications

  • No publications available at this time for this protocol.

Biomarkers

  • No biomarkers available at this time for this protocol.

Data Collections

  • No data collections available at this time for this protocol.
 Team Project
Start Date
May 1 2021
Estimated Finish Date
Feb 1 2022
Finish Date
Nov 17 2021
Protocol ID
493
Protocol Type
Reference Set
Fields of Research
  • Proteomics
Collaborative Group
G.I. and Other Associated Cancers Research Group
Cancer Types
  • Liver cell carcinoma

Associated Forms